Computational function assignment for potential drug targets: from single genes to cellular systems.
Biomedical science is currently undergoing an epoch-marking transition from its classical phase to the post-genome era. The outstanding success of world-wide genome sequencing efforts, evidenced by the recent publication of the draft of the human genome, together with the completion of several genomes of eukaryotic model organisms and the availability of microbial genome sequences, is opening up data sources of unprecedented scale for drug discovery. Furthermore, the elucidation of genome expression states through transcriptomic and proteomic techniques is playing a crucial role in the characterisation of disease at the molecular level. At the same time, our still very limited knowledge of the biological functions of genes and proteins at different levels of cellular organisation is preventing full exploitation of the available data. This review will discuss current computational techniques for function prediction based on the sequence-structure-function paradigm. Newly emerging approaches aimed at gaining an expanded understanding of function through integration of data from various sources and modelling of complex cellular systems will also be highlighted.
Department of Biochemistry and Molecular Biology, University College London. nagl@biochemistry.ucl.ac.uk
S B
SB
Nagl
D000595:Amino Acid Sequence; D019295:Computational Biology / Q000379:methods; D030541:Databases, Genetic; D005796:Genes / Q000502:physiology; D015894:Genome, Human; D006801:Humans; D008954:Models, Biological; D011506:Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology
D011506:Proteins